Literature DB >> 17786981

HDLs activate ADAM17-dependent shedding.

Edwige Tellier1, Matthias Canault, Marjorie Poggi, Bernadette Bonardo, Alain Nicolay, Marie-Christine Alessi, Gilles Nalbone, Franck Peiretti.   

Abstract

The tumor necrosis factor-alpha (TNF) converting enzyme (ADAM17) is a metalloprotease that cleaves several transmembrane proteins, including TNF and its receptors (TNFR1 and TNFR2). We recently showed that the shedding activity of ADAM17 is sequestered in lipid rafts and that cholesterol depletion increased the shedding of ADAM17 substrates. These data suggested that ADAM17 activity could be regulated by cholesterol movements in the cell membrane. We investigated if the membrane cholesterol efflux induced by high-density lipoproteins (HDLs) was able to modify the shedding of ADAM17 substrates. HDLs added to different cell types, increased the ectodomain shedding of TNFR2, TNFR1, and TNF, an effect reduced by inhibitors active on ADAM17. The HDLs-stimulated TNF release occurred also on cell-free isolated plasma membranes. Purified apoA1 increased the shedding of TNF in an ABCA1-dependent manner, suggesting a role for the cholesterol efflux in this phenomenon. HDLs reduced the cholesterol and proteins (including ADAM17) content of lipid rafts and triggered the ADAM17-dependent cleavage of TNF in the non-raft region of the membrane. In conclusion, these data demonstrate that HDLs alter the lipid raft structure, which in turn activates the ADAM17-dependent processing of transmembrane substrates. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17786981     DOI: 10.1002/jcp.21265

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  19 in total

Review 1.  Role of lipid rafts in liver health and disease.

Authors:  Angela Dolganiuc
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

3.  Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.

Authors:  Juan Li; Bin Liu; Xiaofei Gao; Zhixing Ma; Tianyi CaoSong; Yan-ai Mei; Yufang Zheng
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

Review 4.  Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling.

Authors:  Michael B Fessler; John S Parks
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

5.  ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.

Authors:  Kai Yin; Duan-fang Liao; Chao-ke Tang
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

Review 6.  Regulation of ABCA1 functions by signaling pathways.

Authors:  Yuhua Liu; Chongren Tang
Journal:  Biochim Biophys Acta       Date:  2011-09-05

7.  Molecular consequences of altered neuronal cholesterol biosynthesis.

Authors:  Zeljka Korade; Anne K Kenworthy; Károly Mirnics
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

Review 8.  High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.

Authors:  S-H Wang; S-G Yuan; D-Q Peng; S-P Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

9.  The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor.

Authors:  Chongren Tang; Yuhua Liu; Peter S Kessler; Ashley M Vaughan; John F Oram
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

10.  ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study.

Authors:  M Junyent; L D Parnell; C-Q Lai; D K Arnett; M Y Tsai; E K Kabagambe; R J Straka; M Province; P An; C E Smith; Y-C Lee; I Borecki; J M Ordovás
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-10-09       Impact factor: 4.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.